NCT04812600

Brief Summary

This study will examine the impact of cardiac rehabilitation on blood vessel health using a newly developed microfluidic-based tactile sensor to assess blood vessel health. The participants will have their blood vessel health measured using a sensor that is placed on top of the skin over the artery before and after exercise (1, 3, 5, 10, 30 and 60 mins). The investigators will study these responses at the first session of cardiac rehabilitation and following 1 and 4 weeks of cardiac rehabilitation (sessions 3 and 6). The investigators will also collect some information from the medical record regarding: age, gender, body mass index, resting cardiovascular measures (heart rate, blood pressure etc), medications, reasons which qualified the participant into cardiac rehabilitation, blood tests related to heart or cardiovascular function, metabolic panel, lipid panel, echocardiogram results, recorded electrocardiogram, known vascular diseases, presence of implantable devices, Seattle Heart Failure Model data and cardiovascular measures and exercise workloads during cardiac rehabilitation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 17, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

March 20, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 23, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2022

Completed
Last Updated

March 23, 2021

Status Verified

March 1, 2021

Enrollment Period

1 year

First QC Date

March 17, 2021

Last Update Submit

March 19, 2021

Conditions

Keywords

Exercisevascular diseasecardiac rehabilitation

Outcome Measures

Primary Outcomes (4)

  • Micro-tactile sensor assessment of arterial stiffness change to exercise

    Elasticity (unit measure: pascal) of arterial wall will be assessed.

    The change of up to 1 hour post exercise relative to pre-exercise, at 0 weeks, 1 week and 4 weeks of cardiac rehabilitation

  • Micro-tactile sensor assessment of arterial viscosity change to exercise

    Damping (unit measure: pascal x sec) of the arterial wall will be assessed.

    The change of up to 1 hour post exercise relative to pre-exercise, at 0 weeks, 1 week and 4 weeks of cardiac rehabilitation

  • Micro-tactile sensor assessment of arterial radius change to exercise

    Size of the artery lumen (unit measure: mm) will be assessed.

    The change of up to 1 hour post exercise relative to pre-exercise, at 0 weeks, 1 week and 4 weeks of cardiac rehabilitation

  • Automated blood pressure device assessment of systolic and diastolic blood pressure change to exercise

    Systolic and diastolic blood pressure (unit measure: mmHg) of the artery will be assessed.

    The change of up to 1 hour post exercise relative to pre-exercise, at 0 weeks, 1 week and 4 weeks of cardiac rehabilitation

Study Arms (1)

Cardiac Rehabilitation

Individuals assigned to phase II (outpatient) cardiac rehabilitation program will undergo their normal exercise routines while the investigators make the measurements pre and post exercise at 0 week, and following 1 and 4 weeks of exercise.

Eligibility Criteria

Age45 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals who are undergoing Phase II (outpatient) cardiac rehabilitation at Sentara Heart Hospital (Norfolk, Va) and meet the inclusion and exclusion criteria listed will be recruited for the study.

You may qualify if:

  • Age 45-70
  • Subjects who qualify for cardiac rehabilitation via doctor's orders

You may not qualify if:

  • ●Physical limitations which would preclude one from performing exercise.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sentara Heart Hospital

Norfolk, Virginia, 23501, United States

RECRUITING

MeSH Terms

Conditions

Cardiovascular DiseasesMotor ActivityVascular Diseases

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Julie Hao, Ph.D.

    Old Dominion University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Julie Hao, Ph.D.

CONTACT

Leryn Reynolds

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 17, 2021

First Posted

March 23, 2021

Study Start

March 20, 2021

Primary Completion

March 20, 2022

Study Completion

March 20, 2022

Last Updated

March 23, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations